Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MMLV REVERSE TRANSCRIPTASE MUTANT
Document Type and Number:
WIPO Patent Application WO/2024/092713
Kind Code:
A1
Abstract:
Disclosed in the present invention is an MMLV reverse transcriptase mutant. Compared with the amino acid sequence of wild-type MMLV reverse transcriptase, the MMLV reverse transcriptase mutant provided in the present invention has mutations at a plurality of sites, for example, site 62, and has the characteristics of improved template conversion performance, improved non-template base addition performance or improved heat resistance. The present invention screens for an MMLV reverse transcriptase mutant having improved conversion performance compared with wild-type templates and further having improved non-template base addition performance or thermal stability. The selected mutant is suitable for RNA sequencing, such as Smart-Seq, nanopore sequencing, and 5'RACE, using a template conversion-based library preparation method, and can also be applied to RT-qPCR and the like.

Inventors:
ZHANG XIAOHONG (CN)
CAO RUYIN (CN)
LIU XIAOCHEN (CN)
CHEN XUEMEI (CN)
XIE QINGQING (CN)
ZHENG YUE (CN)
DONG YULIANG (CN)
ZHANG WENWEI (CN)
Application Number:
PCT/CN2022/129844
Publication Date:
May 10, 2024
Filing Date:
November 04, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BGI SHENZHEN (CN)
International Classes:
C12N9/12; C12N15/52; C12N15/63; C12Q1/6844; C12Q1/6869
Attorney, Agent or Firm:
JEEKAI&PARTNERS (CN)
Download PDF: